课题基金 / 基金详情

Thrombin mediated cytotoxicity during cerebral ischemia

Thrombin mediated cytotoxicity during cerebral ischemia
脑缺血期间凝血酶介导的细胞毒性
批准号:
10327599
负责人:
Patrick D Lyden
金额:
$32.39万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-15 至 2021-05-31

项目摘要

项目成果

Patrick D Lyden的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We propose a novel and exciting hypothesis—based on literature and our own pilot data—that neuronal injury stimulates astrocyte activation via thrombin and its receptor PAR-1, and the resulting astrocyte response to injury yields transmissible paracrine protection of neurons. Together, neurons, astroctyes, endothelial cells, pericytes, and oligodendroglia comprise the neurovascular unit, or NVU. Data generated from the several aims will yield insights into the mechanism for the well-documented phenomenon of pre-conditioning; will provide considerable insights into the mechanisms of differential vulnerability to cerebral injury; and would likely yield treatment options for stroke patients. To accomplish the aims, we are creating novel conditional knock-out mice that will provide research tools to the broader research field. The previous award, R01 NS075930, covered 8/15/2011 to 03/31/2015 and involved 4 aims. All proposed work has been completed and published or under review. The data from our prior award has already influenced stroke care significantly, in the form of two funded clinical trials. However, our prior data could not fully explain the known differences among the elements of the NVU, specifically, that astrocytes and endothelial cells tolerate ischemia better than neurons. What is the mechanism of thrombin-mediated pre-conditioning, and can we relate that mechanism to other forms of pre- and peri-conditioning? Why does the brain contain prothrombin mRNA and protein and what purpose could be served by thrombin activation in brain? Could we derive insights about the response of the brain to injury, and specifically explore the cell-subtype interactions during injury among astrocytes, neurons, pericytes, oligodendroglia, and endothelial cells? To answer these questions, and to address the central hypothesis of the present award application, we added significant new models to our repertoire, and generated pilot data speaking to the feasibility and novelty of the proposed new specific aims.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Current Advances in the Use of Therapeutic Hypothermia.
低温治疗应用的最新进展。
DOI: 10.1089/ther.2019.29070.jjl
发表时间: 2020
期刊: Therapeutic hypothermia and temperature management
影响因子: 1.2
作者: [Lundbye,Justin, Badjatia,Neeraj, Polderman,KeesH, Lyden,Patrick]
通讯作者: Lyden,Patrick
DOI: 10.1161/strokeaha.113.004488
发表时间: 2014-03
期刊: Stroke
影响因子: 8.3
作者: [Lyden P, Pereira B, Chen B, Zhao L, Lamb J, Lei IF, Rajput P]
通讯作者: Rajput P
DOI: 10.1016/j.neuroscience.2014.09.038
发表时间: 2014-12-05
期刊: NEUROSCIENCE
影响因子: 3.3
作者: [Rajput, P. S., Lyden, P. D., Chen, B., Lamb, J. A., Pereira, B., Lamb, A., Zhao, L., Lei, I. -F., Bai, J.]
通讯作者: Bai, J.
Missing outcome data management in acute stroke trials testing iv thrombolytics. Is there risk of bias?
测试静脉溶栓剂的急性卒中试验中缺失结果数据管理。
DOI: 10.1177/2396987320905457
发表时间: 2020
期刊: European stroke journal
影响因子: 6.1
作者: [Fernandez-Ferro,Jose, Schwamm,LeeH, Descalzo,MiguelA, MacIsaac,Rachael, Lyden,PatrickD, Lees,KennedyR]
通讯作者: Lees,KennedyR
The NIH SPAN Coordinating Center
  • 批准号:
    10591751
  • 项目类别:
  • 资助金额:
    $100.85万
  • 财政年份:
    2023
  • 负责人:
    Patrick D Lyden
  • 依托单位:
ZZ-3K3A-301: A multicenter, randomized, placebo-controlled, double-blinded, Phase 3 study to evaluate the efficacy and safety of 3K3A-APC (RHAPSODY-2)
  • 批准号:
    10305528
  • 项目类别:
  • 资助金额:
    $398.01万
  • 财政年份:
    2022
  • 负责人:
    Patrick D Lyden
  • 依托单位:
The NIH SPAN Coordinating Center
  • 批准号:
    10074917
  • 项目类别:
  • 资助金额:
    $16.7万
  • 财政年份:
    2020
  • 负责人:
    Patrick D Lyden
  • 依托单位:
The NIH SPAN Coordinating Center
  • 批准号:
    10224355
  • 项目类别:
  • 资助金额:
    $78.29万
  • 财政年份:
    2019
  • 负责人:
    Patrick D Lyden
  • 依托单位:
国内基金
海外基金
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
基于NLRP3/IL-1β信号探讨α7nAChR介导巨噬细胞—心肌细胞互作在Aβ诱导房颤心房重构中的作用及机制研究
Tom1L1在胞内体蛋白分选机制中功能的研究
  • 批准号:
    31171289
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2011
  • 负责人:
    刘宁生
  • 依托单位:
溶酶体依赖性TRAF2降解的机制
  • 批准号:
    30971501
  • 项目类别:
    面上项目
  • 资助金额:
    31.0万元
  • 批准年份:
    2009
  • 负责人:
    李联运
  • 依托单位: